To better characterize this population of GBM cells, we compared the proteome of TM-GBM cells with that of SVZ-GBM cells, and identified a differentially expressed protein belonging to the B7-family members of immune checkpoints, B7-H3. The gene discussed is CD276; the disease is glioblastoma.